Federal contractor · LAWRENCEVILLE, NJ

BRISTOL-MYERS SQUIBB COMPANY

BRISTOL-MYERS SQUIBB COMPANY received $8.8M in federal contract obligations in FY2026, on 73 awards (+16% vs FY2025). Since FY2022: $21.2M. Its largest customer was Department of Veterans Affairs ($8.8M).

Obligations · FY2026: $8.8M
New awards: 73
Sole-source: 0.0%
Single offer: 74%

UEI: UFGKB2B71N12

Other than small business

Open in the contracts explorer Relationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

312.7KFY2022
947.2KFY2023
3.4MFY2024
7.6MFY2025
8.8MFY2026

Top buying agencies

Obligations in FY2026.

Department of Veterans Affairs$8.8M99.7%
71 awards
Federal Prison System / Bureau of Prisons$22.6K0.3%
2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Health & medical$8.8M100%

Where the work was performed

Mercer County, NJ$6M67%
Shelby County, TN$2.9M33%

Integrity signals

Shares of the year's obligations, next to the country's.

Low competition74%
US 39% · $6.5M
Sole-source awards0.0%
US 30% · $0
Single-offer competitions74%
US 8.7% · $6.5M
Urgency justifications12%
US 5.1% · $1.1M

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS$848.4K
Department of Veterans Affairs· Mercer County, NJ· Health & medical· Dec 31, 2025 – Dec 31, 2025· 36C25226N0198
ABECMA INJECTION$378.7K
Department of Veterans Affairs· Mercer County, NJ· Health & medical· Aug 6, 2026 – Aug 6, 2026· 36C24926N0651
ABECMA FOR CAR-T$378.7K
Department of Veterans Affairs· Mercer County, NJ· Health & medical· Feb 19, 2026 – Apr 17, 2026· 36C24926F0096
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)$371.3K
Department of Veterans Affairs· Shelby County, TN· Health & medical· Feb 11, 2026 – Sep 24, 2026· 36C24526N0290
BREYANZI CAR T - TRANSPLANT$364.1K
Department of Veterans Affairs· Mercer County, NJ· Health & medical· Jun 16, 2026 – Jun 16, 2026· 36C24926N0590
BREYANZI CAR T - TRANSPLANT$364.1K
Department of Veterans Affairs· Mercer County, NJ· Health & medical· Jun 16, 2026 – Jun 16, 2026· 36C24926N0591
BREAYNAZI FOR CAR-T TRANSPLANT MEDICATION$364.1K
Department of Veterans Affairs· Mercer County, NJ· Health & medical· Jun 2, 2026 – Jun 2, 2026· 36C24926N0433
BREYANZI INJECTION$364.1K
Department of Veterans Affairs· Mercer County, NJ· Health & medical· Aug 6, 2026 – Aug 6, 2026· 36C24926N0658

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 2 markets (agency × industry), FY2024–FY2026.

RLS (USA) INC.$17.8M+56% in FY2026
LAKE ZURICH, IL · 86% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing
GOLDEN STATE MEDICAL SUPPLY, INC.$16.2M−99% in FY2026
CAMARILLO, CA · 80% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing
FFF ENTERPRISES, INC.$17.7M−81% in FY2026
TEMECULA, CA · 83% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

BRISTOL-MYERS SQUIBB COMPANYAI match · 100%

Lobbying · 2025: $10.1M; 32 reports
Lobbying · 2023–2026: $28.7M; $28.7M in its own reports
PAC giving · 2026: $344.5K; 1 PAC

Lobbying by year

2023$8.9M
37 reports
2024$5.3M
35 reports
2025$10.1M
32 reports
2026$4.5M
27 reports

Top issues

Medicare and Medicaid107 reports
Health issues95 reports
Budget and appropriations26 reports
Taxation and the Internal Revenue Code26 reports
Copyright, patent and trademark25 reports
Trade (domestic and foreign)25 reports
Pharmacy13 reports
Medical and disease research, clinical labs2 reports

Who was contacted

U.S. SENATE110 reports
U.S. HOUSE OF REPRESENTATIVES100 reports
Centers For Medicare and Medicaid Services (CMS)35 reports
Food & Drug Administration (FDA)2 reports
White House Office2 reports
Executive Office of the President (EOP)1 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

Todd Strategy Group$960K
15 reports
Tarplin, Downs & Young, LLC$880K
14 reports
SPLITOAK STRATEGIES LLC$620K
14 reports
FEDERAL STREET STRATEGIES, LLC$620K
14 reports
Crossroads Strategies, LLC$480K
13 reports
The McManus Group$320K
4 reports
Williams and Jensen, PLLC$290K
4 reports
Tiber Creek Group$240K
9 reports

16 firms in all. Registrants who are individuals are counted, not named.

PAC giving to candidates by party, 2026 cycle

Republican$201K58%
Democratic$143.5K42%

PACs sponsored

BRISTOL-MYERS SQUIBB COMPANY POLITICAL ACTION COMMITTEE$671K raised this cycle

PACs these organizations sponsor (connected organizations in FEC records). A PAC gives employees' and members' voluntary contributions, not the company's own money.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Sep 30, 2026.

Congress: members and bills

Through the organizations matched to this company: members of Congress whose campaigns received contributions from their PACs, and the bills their lobbying reports named. Shown beside the company's contracts as a comparison, not a cause.

Members whose campaigns received from its PACs, 2026 cycle

Suzan K. DelBene$10K
D-WA-1 · House · 1 PAC
Brett Guthrie$10K
R-KY-2 · House · 1 PAC
Diana Harshbarger$10K
R-TN-1 · House · 1 PAC
John Joyce$10K
R-PA-13 · House · 1 PAC
Jason Smith$10K
R-MO-8 · House · 1 PAC
Brian Jack$9,000
R-GA-3 · House · 1 PAC
Richard Hudson$8,000
R-NC-9 · House · 1 PAC
Brendan F. Boyle$7,500
D-PA-2 · House · 1 PAC
Bradley Scott Schneider$7,000
D-IL-10 · House · 1 PAC
H. Morgan Griffith$6,000
R-VA-9 · House · 1 PAC

$343.5K of the $344.5K its PACs gave to federal candidates went to 114 members of Congress.

Members whose campaigns received from its PACs, 2024 cycle

John Barrasso$10K
R-WY · Senate · 1 PAC
Suzan K. DelBene$10K
D-WA-1 · House · 1 PAC
Tom Emmer$10K
R-MN-6 · House · 1 PAC
Brett Guthrie$10K
R-KY-2 · House · 1 PAC
Richard Hudson$10K
R-NC-9 · House · 1 PAC

Direct and in-kind contributions the members' campaigns received (FEC), net of refunds. Party and seat are the member's current or latest.

Bills named in its lobbying reports

H.R. 830 · HELP Copays Act15 reports
118th Congress · Introduced · 2023–2026
H.R. 5378 · Lower Costs, More Transparency Act14 reports
118th Congress · Passed one chamber · 2023–2025
H.R. 5376 · Inflation Reduction Act of 202213 reports
117th Congress · Became law · 2023–2024
S. 1339 · Pharmacy Benefit Manager Reform Act12 reports
118th Congress · Reported by committee · 2023–2025
S. 127 · Pharmacy Benefit Manager Transparency Act of 202310 reports

Amounts, members and bills are as recorded, shown side by side. They say nothing about why a contribution was made, how a member voted or what a report sought. A bill number written in a report is read as the measure of the Congress its context points to (a law's number, the Congress written next to it, the title), else of the Congress then sitting.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.